Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Epidural Stimulation and Buspirone for Forelimb Function in SCI
NCT02313194Phase 2Active, not recruiting
- Sponsor
- University of California, Los Angeles
- Start
- Jul 2013
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, open-label, single-arm trial of buspirone in cervical spinal cord injury, sponsored by University of California, Los Angeles. Primary endpoint: Assessment of arm/hand function at 24 months. Started Jul 2013; status: active, not recruiting.
02
Drugs
buspirone
03
Conditions
cervical spinal cord injury
Beyond the preview
Go deeper on NCT02313194.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02313194.